X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2023/04/05/2641603/0/en/Aeterna-Zentaris-Provides-Update-on-Macrilen-Macimorelin-Reiterates-Advancement-of-Pediatric-DETECT-Trial.html
https://www.globenewswire.com/news-release/2022/08/29/2505902/0/en/Aeterna-Zentaris-Set-to-Regain-Full-Rights-to-Macrilen-Macimorelin-in-U-S-and-Canada-from-Novo-Nordisk.html
https://www.globenewswire.com/news-release/2020/07/30/2070270/0/en/AETERNA-ZENTARIS-ANNOUNCES-ABSTRACT-OF-RESULTS-FROM-FIRST-PEDIATRIC-STUDY-OF-MACIMORELIN-ACCEPTED-FOR-PRESENTATION-AT-THE-22ND-EUROPEAN-CONGRESS-OF-ENDOCRINOLOGY.html
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-november-2018
https://globenewswire.com/news-release/2017/12/20/1267302/0/en/Aeterna-Zentaris-Announces-FDA-Approval-of-Macrilen-macimorelin-for-Diagnosis-of-Adult-Growth-Hormone-Deficiency.html
http://www.businesswire.com/news/home/20170330005118/en/Aeterna-Zentaris-Intends-File-NDA-Respect-Macrilen%E2%84%A2/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
http://www.businesswire.com/news/home/20170307005559/en/Aeterna-Zentaris-Announces-EMA-Pediatric-Committee-Agreement/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
Market Place
Share 
